Active Projects
September 2024 – June 2029
Engineering AAV for safe and efficient gene delivery to the human retina
CO-PI: Robert Mckenna
Sponsor: NIH/NEI
May 2024 – May 2027
Measuring Exocrine Pancreas Metabolism in Type 1 Diabetes
PI: Anna Rushin
Sponsor: NATL INST OF HLTH NIDDK
May 2024 – January 2028
AAV capsids and their cellular interactions
PI: Robert Mckenna
Sponsor: NIH/NIGMS
April 2024 – April 2027
Accessible Epigenetic biomarkers for “Climate Readiness”: from Mouse to Human
CO-PI: Michael Kladde
Sponsor: US ARMY MED RES ACQUISITION
April 2024 – March 2029
Targeting Glycogen Metabolism in Ewing’s Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications
PI: Ramon Sun
Sponsor: NIH/NCI
March 2024 – February 2029
Taperin-based macromolecular complex at the base of stereocilia
PI: Craig Vander Kooi
Sponsor: INDIANA UNIV via NIH/NIDCD
January 2024 – December 2027
Leaving no child behind: enabling universal access to AAV gene therapies by vector bio-engineering to evade pre-existing natural immunity
PI: Robert Mckenna
Sponsor: CHILDRENS MEDICAL RESEARCH INSTITUTE via NATL HEALTH AND MED RESEARCH COUNCIL
January 2024 – December 2028
A modified arrestin1 to enhance glycolysis in photoreceptors as a therapeutic approach to slowing retinal degeneration
CO-PI: Robert Mckenna
Sponsor: NIH/NEI
August 2023 – July 2028
Molecular mechanisms for regulating microRNA levels in metazoans
PI: Mingyi Xie
Sponsor: NIH/NIGMS
July 2023 – June 2028
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
PI: Mingyi Xie
Sponsor: NIH/NCI
May 2023 – may 2027
Deciphering the Glycan Code in Human Alzheimer’s Disease Brain
PI: Ramon Sun
Sponsor: NIH/NIA
July 2026 – June 2028
Structural and Biophysical Characterization of AAV Genome Packaging and Ejection for Enhanced Vector Design
PI: Antonette Bennett
Sponsor: NIH
September 2026 – June 2031
Molecular mechanisms of Schlafen-mediated phage defense
PI: Artem Nemudryi
Sponsor: NIH
January 2023 – 2027
National High Magnetic Field Laboratory Renewal 2023-2027
PI: Joanna Long
Sponsor: NSF (FSU Sub)
November 2022 – July 2027
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
PI: Ramon Sun
Sponsor: NIH/NCI
Completed Projects
PI: Matthew Gentry
Defining APBD pre-clinical biomarkers and assessing a therapy in an APBD mouse model.
Sponsor: Million Dollar Bike Ride – APBD Foundation
Type: Foundation
Total Awarded: $49,677
Sponsor: The V Foundation for Cancer Research
Type: Foundation
Total Awarded: $62,192
September 2024 – September 2025
Functional amyloid formation in streptococcus mutans
CO-PI: Joanna Long
Sponsor: NIH/NIDCR
January 2024 – DEcember 2025
The molecular basis of 7SK RNA methylation in non-small cell lung cancer
PI: Mingyi Xie
Sponsor: NIH/NCI
September 2022 – May 2025
GIPC3, Multifunctional Myosin Adaptor in Mammalian Auditory Hair Cells
PI: Craig Vander Kooi
Sponsor: NIH/NIAID
September 2022 – June 2026
Platelet Metabolism in Diabetes Mellitus
PI: Matthew Gentry
Sponsor: UNIV OF KENTUCKY via NIH/NHLBI
May 2023 – March 2026
Elucidating and targeting INSL4 signaling in lung cancer
CO-PI: Jianrong Lu
Sponsor: FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE